ID   ARY2_RAT                Reviewed;         290 AA.
AC   P50298;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   24-JUL-2024, entry version 128.
DE   RecName: Full=Arylamine N-acetyltransferase 2 {ECO:0000305};
DE            EC=2.3.1.5 {ECO:0000269|PubMed:7882993, ECO:0000269|PubMed:8761433};
DE   AltName: Full=Arylamide acetylase 2;
DE   AltName: Full=N-acetyltransferase type 2;
DE            Short=AT-2;
DE            Short=NAT-2;
DE   AltName: Full=N-hydroxyarylamine O-acetyltransferase;
DE            EC=2.3.1.118 {ECO:0000250|UniProtKB:P11245};
GN   Name=Nat2; Synonyms=Aac2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], CATALYTIC ACTIVITY, AND FUNCTION.
RC   STRAIN=Wistar; TISSUE=Pineal gland;
RX   PubMed=7882993; DOI=10.1111/j.1432-1033.1995.tb20240.x;
RA   Ebisawa T., Sasaki Y., Deguchi T.;
RT   "Complementary DNAs for two arylamine N-acetyltransferases with identical
RT   5' non-coding regions from rat pineal gland.";
RL   Eur. J. Biochem. 228:129-137(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND ALLELE NAT2*21.
RC   STRAIN=WKY/NCRLBR; TISSUE=Heart;
RX   PubMed=8528272; DOI=10.1097/00008571-199508000-00009;
RA   Doll M.A., Hein D.W.;
RT   "Cloning, sequencing and expression of NAT1 and NAT2 encoding genes from
RT   rapid and slow acetylator inbred rats.";
RL   Pharmacogenetics 5:247-251(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=8761433; DOI=10.1093/carcin/17.8.1729;
RA   Jones R.F., Land S.J., King C.M.;
RT   "Recombinant rat and hamster N-acetyltransferases-1 and -2: relative rates
RT   of N-acetylation of arylamines and N,O-acyltransfer with arylhydroxamic
RT   acids.";
RL   Carcinogenesis 17:1729-1733(1996).
CC   -!- FUNCTION: Catalyzes the N- or O-acetylation of various arylamine and
CC       heterocyclic amine substrates. Participates in the detoxification of a
CC       plethora of hydrazine and arylamine drugs. {ECO:0000269|PubMed:7882993,
CC       ECO:0000269|PubMed:8761433}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=acetyl-CoA + an arylamine = an N-acetylarylamine + CoA;
CC         Xref=Rhea:RHEA:16613, ChEBI:CHEBI:13790, ChEBI:CHEBI:50471,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57288; EC=2.3.1.5;
CC         Evidence={ECO:0000269|PubMed:7882993, ECO:0000269|PubMed:8761433};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16614;
CC         Evidence={ECO:0000305|PubMed:7882993, ECO:0000305|PubMed:8761433};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=acetyl-CoA + an N-hydroxyarylamine = an N-acetoxyarylamine +
CC         CoA; Xref=Rhea:RHEA:20277, ChEBI:CHEBI:13792, ChEBI:CHEBI:21494,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57288; EC=2.3.1.118;
CC         Evidence={ECO:0000250|UniProtKB:P11245};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=32.2 uM for 2-aminofluorene {ECO:0000269|PubMed:8761433};
CC         KM=138 uM for 4-aminoazobenzene {ECO:0000269|PubMed:8761433};
CC         Vmax=59 nmol/min/mg enzyme toward 4-aminoazobenzene
CC         {ECO:0000269|PubMed:8761433};
CC         Vmax=833 nmol/min/mg enzyme toward 2-aminofluorene
CC         {ECO:0000269|PubMed:8761433};
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- POLYMORPHISM: There are two forms of NAT2: a rapid isoform (NAT2*21A)
CC       and a slow isoform (NAT2*21B).
CC   -!- SIMILARITY: Belongs to the arylamine N-acetyltransferase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U01348; AAA70161.1; -; mRNA.
DR   EMBL; U23418; AAB53956.1; -; Genomic_DNA.
DR   EMBL; U19272; AAB60501.1; -; Genomic_DNA.
DR   EMBL; U17261; AAA56772.1; -; mRNA.
DR   PIR; I58425; I58425.
DR   RefSeq; NP_446306.1; NM_053854.1.
DR   AlphaFoldDB; P50298; -.
DR   SMR; P50298; -.
DR   STRING; 10116.ENSRNOP00000051430; -.
DR   iPTMnet; P50298; -.
DR   PhosphoSitePlus; P50298; -.
DR   PaxDb; 10116-ENSRNOP00000051430; -.
DR   Ensembl; ENSRNOT00055006442; ENSRNOP00055004934; ENSRNOG00055004040.
DR   Ensembl; ENSRNOT00055006448; ENSRNOP00055004940; ENSRNOG00055004040.
DR   Ensembl; ENSRNOT00055006452; ENSRNOP00055004943; ENSRNOG00055004040.
DR   Ensembl; ENSRNOT00055006453; ENSRNOP00055004944; ENSRNOG00055004040.
DR   Ensembl; ENSRNOT00055006457; ENSRNOP00055004948; ENSRNOG00055004040.
DR   Ensembl; ENSRNOT00060027262; ENSRNOP00060021873; ENSRNOG00060015924.
DR   Ensembl; ENSRNOT00060027272; ENSRNOP00060021881; ENSRNOG00060015924.
DR   Ensembl; ENSRNOT00060027279; ENSRNOP00060021886; ENSRNOG00060015924.
DR   Ensembl; ENSRNOT00060027288; ENSRNOP00060021892; ENSRNOG00060015924.
DR   Ensembl; ENSRNOT00060027292; ENSRNOP00060021894; ENSRNOG00060015924.
DR   Ensembl; ENSRNOT00065007267; ENSRNOP00065005043; ENSRNOG00065004978.
DR   Ensembl; ENSRNOT00065007268; ENSRNOP00065005044; ENSRNOG00065004978.
DR   GeneID; 116632; -.
DR   KEGG; rno:116632; -.
DR   UCSC; RGD:70492; rat.
DR   AGR; RGD:70492; -.
DR   CTD; 10; -.
DR   RGD; 70492; Nat2.
DR   eggNOG; ENOG502RD0D; Eukaryota.
DR   InParanoid; P50298; -.
DR   OrthoDB; 2696539at2759; -.
DR   BRENDA; 2.3.1.56; 5301.
DR   Reactome; R-RNO-156582; Acetylation.
DR   Reactome; R-RNO-9753281; Paracetamol ADME.
DR   SABIO-RK; P50298; -.
DR   PRO; PR:P50298; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0004060; F:arylamine N-acetyltransferase activity; IDA:RGD.
DR   GO; GO:0008080; F:N-acetyltransferase activity; IDA:RGD.
DR   GO; GO:0046990; F:N-hydroxyarylamine O-acetyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0048565; P:digestive tract development; IEP:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IEP:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   Gene3D; 3.30.2140.20; -; 1.
DR   InterPro; IPR001447; Arylamine_N-AcTrfase.
DR   InterPro; IPR053710; Arylamine_NAT_domain_sf.
DR   InterPro; IPR038765; Papain-like_cys_pep_sf.
DR   PANTHER; PTHR11786:SF8; ARYLAMINE N-ACETYLTRANSFERASE 1; 1.
DR   PANTHER; PTHR11786; N-HYDROXYARYLAMINE O-ACETYLTRANSFERASE; 1.
DR   Pfam; PF00797; Acetyltransf_2; 1.
DR   PRINTS; PR01543; ANATRNSFRASE.
DR   SUPFAM; SSF54001; Cysteine proteinases; 1.
PE   1: Evidence at protein level;
KW   Acyltransferase; Cytoplasm; Reference proteome; Transferase.
FT   CHAIN           1..290
FT                   /note="Arylamine N-acetyltransferase 2"
FT                   /id="PRO_0000107912"
FT   ACT_SITE        68
FT                   /note="Acyl-thioester intermediate"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        107
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        122
FT                   /evidence="ECO:0000250"
FT   BINDING         103
FT                   /ligand="CoA"
FT                   /ligand_id="ChEBI:CHEBI:57287"
FT                   /evidence="ECO:0000250"
FT   BINDING         104
FT                   /ligand="CoA"
FT                   /ligand_id="ChEBI:CHEBI:57287"
FT                   /evidence="ECO:0000250"
FT   BINDING         106..107
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         208
FT                   /ligand="CoA"
FT                   /ligand_id="ChEBI:CHEBI:57287"
FT                   /evidence="ECO:0000250"
FT   VARIANT         121
FT                   /note="V -> I (in allele NAT2*21; slow acetylator)"
FT                   /evidence="ECO:0000269|PubMed:8528272"
FT   VARIANT         266
FT                   /note="V -> I (in allele NAT2*21; slow acetylator)"
FT                   /evidence="ECO:0000269|PubMed:8528272"
SQ   SEQUENCE   290 AA;  33756 MW;  A02BF839A230F84D CRC64;
     MDIEAYFERI GYQSSRNKLD LEELTEILQH QIRAIPFENL NIHCGESMEL NLEVIFDQVV
     RKKRGGWCLQ VNHLLYWALT KMGFEATMLG GYVFNTPANK YSSGMIHLLV QVTLSGKDYI
     VDAGFGRSYQ MWEPLELTSG KDQPQVPAIF RLTEENGTWY LDQIRREQYV PNQEFVNSDL
     LEKNKYRKIY SFTLEPRTIE DFESINTYLQ TSPASLFTSK SFCSLQTLEG VHCLVGSTLT
     YRRFSYKDNI DLVEFKSLTE EEIEDVLKTI FGVSLERKLV PKHGDRFFTI
//
